Works about CYSTEAMINE


Results: 216
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults.

    Published in:
    Nephrology Dialysis Transplantation, 2015, v. 30, n. 3, p. 475, doi. 10.1093/ndt/gfu329
    By:
    • Ariceta, Gema;
    • Lara, Enrique;
    • Camacho, Juan A.;
    • Oppenheimer, Federico;
    • Vara, Julia;
    • Santos, Fernando;
    • Muñoz, Miguel Angel;
    • Cantarell, Carmen;
    • Gil Calvo, Marta;
    • Romero, Rafael;
    • Valenciano, Blanca;
    • García-Nieto, Víctor;
    • Sanahuja, Maria José;
    • Crespo, José;
    • Justa, Maria Luisa;
    • Urisarri, Adela;
    • Bedoya, Rafael;
    • Bueno, Alberto;
    • Daza, Antonio;
    • Bravo, Juan
    Publication type:
    Article
    27

    Nephropathic cystinosis: an international consensus document.

    Published in:
    Nephrology Dialysis Transplantation, 2014, v. 29, n. suppl_4, p. iv87, doi. 10.1093/ndt/gfu090
    By:
    • Emma, Francesco;
    • Nesterova, Galina;
    • Langman, Craig;
    • Labbé, Antoine;
    • Cherqui, Stephanie;
    • Goodyer, Paul;
    • Janssen, Mirian C.;
    • Greco, Marcella;
    • Topaloglu, Rezan;
    • Elenberg, Ewa;
    • Dohil, Ranjan;
    • Trauner, Doris;
    • Antignac, Corinne;
    • Cochat, Pierre;
    • Kaskel, Frederick;
    • Servais, Aude;
    • Wühl, Elke;
    • Niaudet, Patrick;
    • Van't Hoff, William;
    • Gahl, William
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

    Published in:
    Cells (2073-4409), 2022, v. 11, n. 1, p. 52, doi. 10.3390/cells11010052
    By:
    • Alonzi, Tonino;
    • Aiello, Alessandra;
    • Petrone, Linda;
    • Najafi Fard, Saeid;
    • D'Eletto, Manuela;
    • Falasca, Laura;
    • Nardacci, Roberta;
    • Rossin, Federica;
    • Delogu, Giovanni;
    • Castilletti, Concetta;
    • Capobianchi, Maria Rosaria;
    • Ippolito, Giuseppe;
    • Piacentini, Mauro;
    • Goletti, Delia
    Publication type:
    Article
    35
    36

    Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa.

    Published in:
    Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. 1, doi. 10.3389/fcimb.2021.718213
    By:
    • Fraser-Pitt, Douglas J.;
    • Dolan, Stephen K.;
    • Toledo-Aparicio, David;
    • Hunt, Jessica G.;
    • Smith, Daniel W.;
    • Lacy-Roberts, Niamh;
    • Nupe Hewage, Piumi Sara;
    • Stoyanova, Teodora N.;
    • Manson, Erin;
    • McClean, Kevin;
    • Inglis, Neil F.;
    • Mercer, Derry K.;
    • O'Neil, Deborah A.
    Publication type:
    Article
    37
    38
    39
    40

    Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence.

    Published in:
    Pharmaceutics, 2023, v. 15, n. 11, p. 2589, doi. 10.3390/pharmaceutics15112589
    By:
    • Castro-Balado, Ana;
    • Cuartero-Martínez, Andrea;
    • Pena-Verdeal, Hugo;
    • Hermelo-Vidal, Gonzalo;
    • Schmidt, Anja;
    • Montero, Belén;
    • Hernández-Blanco, Manuela;
    • Zarra-Ferro, Irene;
    • González-Barcia, Miguel;
    • Mondelo-García, Cristina;
    • Giráldez, María Jesús;
    • Yebra-Pimentel, Eva;
    • Otero-Espinar, Francisco J.;
    • Fernández-Ferreiro, Anxo
    Publication type:
    Article
    41

    Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients.

    Published in:
    Pharmaceutics, 2023, v. 15, n. 7, p. 1851, doi. 10.3390/pharmaceutics15071851
    By:
    • Klank, Sabrina;
    • van Stein, Christina;
    • Grüneberg, Marianne;
    • Ottolenghi, Chris;
    • Rauwolf, Kerstin K.;
    • Grebe, Jürgen;
    • Reunert, Janine;
    • Harms, Erik;
    • Marquardt, Thorsten
    Publication type:
    Article
    42

    Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.

    Published in:
    Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102194
    By:
    • Castro-Balado, Ana;
    • Bandín-Vilar, Enrique;
    • Cuartero-Martínez, Andrea;
    • García-Quintanilla, Laura;
    • Hermelo-Vidal, Gonzalo;
    • García-Otero, Xurxo;
    • Rodríguez-Martínez, Lorena;
    • Mateos, Jesús;
    • Hernández-Blanco, Manuela;
    • Aguiar, Pablo;
    • Zarra-Ferro, Irene;
    • González-Barcia, Miguel;
    • Mondelo-García, Cristina;
    • Otero-Espinar, Francisco J.;
    • Fernández-Ferreiro, Anxo
    Publication type:
    Article
    43

    Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives.

    Published in:
    Pharmaceutics, 2020, v. 12, n. 12, p. 1177, doi. 10.3390/pharmaceutics12121177
    By:
    • Castro-Balado, Ana;
    • Mondelo-García, Cristina;
    • Varela-Rey, Iria;
    • Moreda-Vizcaíno, Beatriz;
    • Sierra-Sánchez, Jesús F.;
    • Rodríguez-Ares, María Teresa;
    • Hermelo-Vidal, Gonzalo;
    • Zarra-Ferro, Irene;
    • González-Barcia, Miguel;
    • Yebra-Pimentel, Eva;
    • Giráldez-Fernández, María Jesús;
    • Otero-Espinar, Francisco J.;
    • Fernández-Ferreiro, Anxo
    Publication type:
    Article
    44
    45
    46
    47
    48
    49